Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Show full item record



Permalink

http://hdl.handle.net/10138/194786

Citation

Eldfors , S , Kuusanmäki , H , Kontro , M , Majumder , M M , Parsons , A , Edgren , H , Pemovska , T , Kallioniemi , O , Wennerberg , K , Gökbuget , N , Burmeister , T , Porkka , K & Heckman , C A 2017 , ' Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia ' , Leukemia , vol. 31 , no. 1 , pp. 51-57 . https://doi.org/10.1038/leu.2016.202

Title: Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
Author: Eldfors, S.; Kuusanmäki, H.; Kontro, M.; Majumder, M. M.; Parsons, Alun; Edgren, H.; Pemovska, T.; Kallioniemi, O.; Wennerberg, K.; Gökbuget, N.; Burmeister, T.; Porkka, K.; Heckman, C. A.
Contributor: University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Clinicum
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Clinicum
University of Helsinki, Institute for Molecular Medicine Finland
Date: 2017
Language: eng
Number of pages: 7
Belongs to series: Leukemia
ISSN: 0887-6924
URI: http://hdl.handle.net/10138/194786
Subject: 3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
leu2016202a.pdf 1.450Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record